| NCT ID | NCT06056037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brown University |
| Condition | Hiv |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2023-10-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HIV (ages 18-24) in Rio de Janeiro, Brazil. The intervention aims to improve social support, self-efficacy for taking ART, and teach skills for problem-solving barriers to promote better adherence.
Eligibility Criteria
Inclusion Criteria: * between 18 and 24 years of age * assigned male sex at birth * identify as a gay or bisexual man, or a transgender woman or another gender identity along the feminine spectrum * self-report living with HIV, and verified by medical chart review, * self-report currently taking or prescribed ART for \> 3 months * self-report missing 2 or more doses of ART medications in any given week in the past month OR not virally suppressed (i.e., \>40 copies/mL in past 3 months; via national outpatient data \[SISCEL\] or plasma viral load testing) * owns a cell phone or willing to use one as part of the study Exclusion Criteria: * unable to give informed consent due to cognitive limitation, severe mental/physical illness or intoxication * unable to read and/or write to an extent that would limit their ability to comprehend the informed consent * lived in the greater Rio de Janeiro area for \< 3 months or planning to move outside the area within the next year
Contact & Investigator
Katie Biello, PhD, MPH
PRINCIPAL INVESTIGATOR
Brown University
Frequently Asked Questions
Who can join the NCT06056037 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 24 Years, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06056037 currently recruiting?
Yes, NCT06056037 is actively recruiting participants. Contact the research team at katie_biello@brown.edu for enrollment information.
Where is the NCT06056037 trial being conducted?
This trial is being conducted at Rio de Janeiro, Brazil.
Who is sponsoring the NCT06056037 clinical trial?
NCT06056037 is sponsored by Brown University. The principal investigator is Katie Biello, PhD, MPH at Brown University. The trial plans to enroll 72 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.